When the Norwegian company that manufactures the Safeback SBX device which is already on the market, approached Eurac Research to have it independently tested, it was clear that the international research team led by physician and researcher Giacomo Strapazzon would publish the results of the study in any case, regardless of the outcome.
For the researchers, the experiment posed a significant challenge, as many participants were completely buried in snow, raising concerns that over two-thirds might require urgent excavation. The volunteer group – composed entirely of enthusiastic ski mountaineers, roughly half of them women – ranged from 23 to 54 years in age. Despite the demanding conditions, the study was conducted under strict monitoring and safety protocols, and everything proceeded smoothly.
Ahead of the coming winter season, after careful analysis and verification, the results of these extreme tests are being published and offer reassurance for all mountain enthusiasts.
"No device can replace precautionary measures," explain Frederik Eisendle and Giacomo Strapazzon, lead authors of the study and members of the Eurac Research team. "Prevention remains the most important tool for saving lives in the mountains. However, our clinical trial shows that this device is highly effective in prolonging survival under the snow and can gain valuable time for rescue operations."
"Considering that asphyxiation is fatal for about two-thirds of critically-buried avalanche victims and death occurs on average within the first 35 minutes, the fact that none of the people involved in the test fell below the 80 percent saturation threshold during this time is truly remarkable," the physicians continue.
The tests were conducted by Eurac Research in collaboration with the University of Bergen, the Haukeland University Hospital (Norway), the Norwegian Air Ambulance Foundation, the Italian national search and rescue organization Corpo Nazionale del Soccorso Alpino e Speleologico (CNSAS), the WSL Institute for Snow and Avalanche Research SLF (Switzerland), the University Hospital Cologne (Germany), the Medical University of Innsbruck (Austria), and the University of Padua (Italy). Logistical support was provided by the Scuola Alpina Guardia di Finanza (SAGF)and the staff of the Rolle Pass ski lifts.
The device exploits the natural porosity of snow—a principle first demonstrated by the same research group—to deliver oxygen-rich air to the nose and mouth via an electric pump. Once activated by a handle on the backpack, the Safeback SBX supplies up to 150 liters of air per minute for as long as 90 minutes. This airflow allows even a small air pocket to sustain a buried person with patent airways for over 35 minutes, despite the accumulation of exhaled carbon dioxide.
Video footage and additional photos available here: https://show.pics.io/safeback_clinical_trial_press/
